The technology at the heart of a global research network
What We Do
uMed is a technology platform embedded within a global network of healthcare providers that automates the process of building high quality prospective research registries
Why it is Unique
While others rely on aggregated data which blocks subject re-engagement, uMed can rapidly reach back to contact patients for clinical studies, engage in data collection from home, and to collect biomarker and genomics samples.
Our Network
Our rapidly growing network now covers millions of patients across the UK and North America.
Our Services
Life Sciences
Build research-grade registry datasets, where patients within those datasets can be re-engaged with full regulatory compliance.
These can be used to support post-market regulatory submissions, payer negotiations and the creation of datasets enhanced with genomic & biomarker samples.
Healthcare Providers
uMed is secure, compliant and zero fee platform that uses EHR data to automate the clinical study process so providers can attract and deliver dozens more studies than is currently possible.
This creates additional revenue and research capacity for sites without increasing overhead or burden on staff.
Patients
Get access to cutting edge clinical trials and enhanced support from your healthcare provider.
Making you aware of all the information and research that might be relevant to you can be a challenge for busy clinicians. uMed helps your healthcare provider to proactively communicate information about your care as well as research opportunities.
Bespoke research opportunities delivered to you
Helping your healthcare provider to bring you better care
Greater transparency and control over your healthcare informationHow does it work?
Step one, build a cohort
Research organisations build a target patient cohort through our international database, derived from anonymised information contained in their electronic health records.
Step two, create an access request
The research organisation creates a research collaboration request which is sent to the healthcare provider. This covers all the relevant information associated with this particular research study. The healthcare provider is alerted to a pending collaboration request and, once approved, the patients will be engaged to participate in that study.
Step three, patient engagement
The specified patients will receive a text message, or telephone call containing a request to take part in the research study from their recognised provider, facilitated by uMed. The accepted patients can be monitored & coordinated remotely without burden to the study site.
Step four, study monitoring
Both the research organisation and healthcare provider will have a full oversight over each study and the associated patient engagement and can continue to monitor through the study.
Privacy
uMed sets a new standard by ensuring patients as well as healthcare providers have transparency, and control over the use of health data.
To find out more contact us for a copy of our Information Governance White Paper.
- GDPR & HIPAA compliant
- ISO 27001 & NHS DSP Toolkit
- SOC2
Our Leadership Team
Our team combines deep expertise in clinical research, drug development, technology and business.
Matt Wilson
Chief Executive Officer
Chris Broderick
Chief Technology Officer
Paul Bleicher
Independent Board Member
Our Vision
uMed seeks to be a cornerstone of the efforts to reduce the burden of disease for patients by radically reducing the barriers to knowledge creation.
Our Partners
We are proud to be partners with some of the world’s leading companies and healthcare providers
Our Investors
Latest News
Careers
We are always looking for talented people to join the uMed family, please send us your CV and get in touch!